PGEN Insider Trading Activity and SEC Form 4 Filings
PGEN insider trading summary
Over the past 12 months, insiders at Precigen, Inc. (PGEN) reported 36 sales worth $43.0M by 6 insiders and 1 open-market purchase worth $25K by 1 insider on SEC Form 4. Net insider selling was $43.0M.
Latest PGEN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 26, 2026 | Jeffrey B Kindler | Director | Sell | $1.4M (185,000 @ $7.44) |
| Aug 25, 2026 | Rutul R Shah | Chief Operating Officer | Sell | $115K (15,342 @ $7.50) |
| Aug 25, 2026 | Phil Tennant | Chief Commercial Officer | Sell | $594K (79,166 @ $7.50) |
| Aug 21, 2026 | Rutul R Shah | Chief Operating Officer | Sell | $260K (34,658 @ $7.50) |
| Aug 21, 2026 | Nancy H Agee | Director | Buy | $25K (3,411 @ $7.23) |
| Aug 6, 2026 | Rutul R Shah | Chief Operating Officer | Sell | $225K (32,739 @ $6.86) |
| Aug 3, 2026 | Rutul R Shah | Chief Operating Officer | Sell | $220K (33,772 @ $6.50) |
| Jul 1, 2026 | Harry Thomasian Jr. | Chief Financial Officer | Sell | $948K (171,429 @ $5.53) |
| Jun 29, 2026 | Rutul R Shah | Chief Operating Officer | Sell | $251K (42,924 @ $5.85) |
| Jun 29, 2026 | Helen Sabzevari | President and CEO | Sell | $2.0M (346,836 @ $5.89) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.